VRTX - What's Going On With Crispr Therapeutics Stock Thursday? | Benzinga
CRISPR Therapeutics AG (NASDAQ: CRSP) shares are trading higher Thursday after the company announced regulatory authorization of the first CRISPR/Cas9 gene-edited therapy.
What Happened: Crispr and Vertex Pharmaceuticals Inc (NASDAQ: VRTX) announced that the United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA) granted the companies conditional marketing authorization for CASGEVY, a CRISPR/Cas9 gene-edited therapy for the treatment of sickle cell disease.
The therapy has ...